[1]. Coronavirus dashboard: current situation in the Netherlands. https://coronadashboard.government.nl/n. Accessed 30 June 2021.
[2]. Statistics Netherlands. Ten thousand COVID-19 deaths during first wave of the pandemic. CBS; 1 October 2020. Available from: https://www.cbs.nl/en-gb/news/2020/40/10-thousand-covid-19-deaths-during-first-wave-of-the-pandemic
[3]. Statistics Netherlands. Deaths; cause of death (extensive list), age and sex. CBS; 11 January 2022. Available from: https://opendata.cbs.nl/statline/#/CBS/en/dataset/7233ENG/table?ts=1646304823895
[4]. Lagerweij G, et al. Staat van Infectieziekten in Nederland, 2019 [The state of infectious diseases in the Netherlands, 2019]. Bilthoven: RIVM, 2021.
[5]. van Lier, A., McDonald, S. A., Bouwknegt, M., et al. Disease burden of 32 infectious diseases in the Netherlands, 2007-2011. PloS one. 2016;11(4), e0153106.
[6]. Wyper, G., Assunção, R., Colzani, E. et al. Burden of disease methods: a guide to calculate COVID-19 disability-adjusted life years. Int J Pub Health 2021;66.
[7]. Murray CJ, Lopez AD. The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge MA: Harvard University Press, 1996.
[8]. Harmans L. Covid-19: Aanzienlijk aantal verloren levensjaren. [COVID-19: Considerable number of lost life-years]. Ned Tijdschr Geneeskd. 2021;165:C4844
[9]. Volksgezondheid Toekomst Verkenning (VTV). Verder kijken dan corona, over de toekomst van onze gezondheid [Looking beyond coronavirus to the future of our health]. Bilthoven: RIVM, 27 Nov 2020. https://www.volksgezondheidtoekomstverkenning.nl/c-vtv/covid-19/ziekte.
[10]. Stichting NICE (Nationale Intensive Care Evaluation). COVID-19 op de IC. [COVID-19 in the ICU]. 2021. Available from: https://stichting-nice.nl/covid-19-op-de-ic.jsp
[11]. Ward M, Brandsema P, Van Straten E, Bosman A. Electronic reporting improves timeliness and completeness of infectious disease notification, The Netherlands, 2003. Eurosurveillance 2005; 10: 7-8.
[12]. Van Asten L, Harmsen CN, Stoeldraijer L, et al. Excess deaths during influenza and coronavirus disease and infection-fatality rate for severe acute respiratory syndrome coronavirus 2, the Netherlands. Emerg Infect Dis. 2021;27(2):411.
[13]. Netherlands National Institute for Public Health and the Environment. PIENTER Corona study: ongoing research on the spread of COVID-19. https://www.rivm.nl/en/pienter-corona-study
[14]. McDonald SA, Miura F, Vos E, et al. Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands. Eur J Epidemiol. 2021.
[15]. Vos ERA, den Hartog G, Schepp RM, et al. Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave. J Epidemiol. Community Health 2020; 75(6):489-495.
[16]. Vos ERA, van Boven M, den Hartog G, et al. Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands. Clin Infect Dis. 2021; 73(12):2318-2321.
[17]. Statistics Netherlands. Werkzame beroepsbevolking; beroep. [Working population; occupation]. https://opendata.cbs.nl/statline/#/CBS/nl/dataset/82808NED/table. Accessed 16 Nov 2020.
[18]. Devleesschauwer B, Havelaar AH, Maertens de Noordhout C, et al. Calculating disability-adjusted life years to quantify burden of disease. Int J Public Health(2014). 59:565–9. DOI: 10.1007/s00038-014-0552-z
[19]. Murray CJ, Salomon JA, Mathers C. A critical examination of summary measures of population health. Bull World Health Org. 2000;78:981-994.
[20]. Schroeder SA. Incidence, prevalence, and hybrid approaches to calculating disability-adjusted life years. Popul Health Metrics 2012;10(1):1-7.
[21]. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2019) Reference Life Table. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2021. http://ghdx.healthdata.org/gbd-2019. Accessed 12 May 2021.
[22]. Burton JK, Reid M, Gribben C, et al.. Impact of COVID-19 on care-home mortality and life expectancy in Scotland. Age & Ageing 2021;50(4):1029-1037.
[23]. Hanlon P, Chadwick F, Shah A, et al. COVID-19–exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study. Wellcome Open Res. 2020:5.
[24]. Ferenci T. Different approaches to quantify years of life lost from COVID-19. Eur J Epidemiol. 2021;36(6):589-597.
[25]. Statistics Netherlands. Overledenen per maand naar Wlz-gebruik, leeftijd en doodsoorzaak COVID-19, 2020 en 2021 (tot en met november). [Monthly deaths according to use of compulsory contribution long-term care, age, and COVID-19 cause of death in 2020 and 2021 (until November)]. 25 March 2022. Available from: https://www.monitorlangdurigezorg.nl/publicaties/maatwerk-publicaties/2022/03/25/overledenen-per-maand-naar-wlz-gebruik--leeftijd-en-doodsoorzaak-covid-19-2020--2021-tm-november. Accessed 28 March 2022.
[26]. Statistics Netherlands. Monitoring Long-term Care: Use of compulsory contribution long-term care by care type, care package, and region. Available from: https://mlzopendata.cbs.nl/#/MLZ/nl/dataset/40055NED/table?dl=63D29. Accessed 15 March 2022.
[27]. De Gier B, Lima PDOB, van Gaalen RD, et al. Occupation-and age-associated risk of SARS-CoV-2 test positivity, the Netherlands, June to October 2020. Eurosurveill. 2021;25(50):2001884.
[28]. World Health Organisation (WHO). WHO methods and data sources for global burden of disease estimates 2000-2011. Geneva: World Health Organisation, 2013.
[29]. Reukens D, van Asten L, Brandsema P, et al. Annual report: Surveillance of COVID-19, influenza and other respiratory infections in the Netherlands: winter 2020/2021. RIVM report no. 2020-0133. 2021 (to appear). Bilthoven: RIVM.
[30]. Hilderink HB, Plasmans MH, Poos MR, et al. Dutch DALYs, current and future burden of disease in the Netherlands. Arch Pub Health 2020;78(1):1-10.
[31]. Wyper GMA, Fletcher E, Grant I. et al.. Measuring the direct population impact of COVID-19 in Scotland, 2020. Arch Pub Health 2022;80:1-10.
[32] Rommel A, von der Lippe E, Plass D, et al. The COVID-19 disease burden in Germany in 2020: Years of life lost to death and disease over the course of the pandemic. Deutsches Ärzteblatt International 2021;118(9):145-151. DOI: 10.3238/arztebl.m2021.0147
[33]. Cuschieri S, Calleja N, Devleesschauwer B, et al. Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year. BMC Pub Health 2021;21:1827.
[34]. Statistics Netherlands. 1.6 thousand COVID-19 deaths in March. CBS; 1 July 2021. Available from: https://www.cbs.nl/en-gb/news/2021/26/1-6-thousand-covid-19-deaths-in-march.
[35]. Wyper G, Devleesschauwer B, Mathers CD, et al. Years of life lost methods must remain fully equitable and accountable. Eur J Epidemiol. 2022;37:215-216.
[36]. Mikkelsen, M. E., Abramoff, M. B., Elmore, J. G., & Kunins, L. COVID-19: Evaluation and management of adults following acute viral illness. UpToDate 2021. https://www.uptodate.com/contents/covid-19-evaluation-and-management-of-adults-following-acute-viral-illness. Accessed 5 Aug 2021.
[37]. Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, Banerjee A. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372.
[38]. Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021; 398:P747-758.
[39]. Ferland L, Dias JG, Carvalho C, et al. Risk of hospitalization and risk of death for healthcare workers with COVID-19 in nine European Union/European Economic Area countries, January 2020–January 2021. medRxiv. 2021. DOI: 10.1101/2021.03.01.21252651
[40]. van Giessen A, de Wit GA, van den Brink C, et al. Impact van de eerste COVID-19 golf op de reguliere zorg en gezondheid. [Impact of the first COVID-19 wave on regular health care and health]. Bilthoven, Netherlands: RIVM, 2020. Available at: https://www.rivm.nl/bibliotheek/rapporten/2020-0183.pdf. DOI: 10.21945/RIVM-2020-0183.
[41]. Knight D, Downes K, Munipalli B, et al. Symptoms and clinical outcomes of coronavirus disease 2019 in the outpatient setting. SN Compr Clin Med. 2021;3(1):247-254.
[42]. Centers for Disease Control (CDC). Clinical care information for COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care.html. Accessed 3 Aug 2021.
[43]. Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Global Health 2015;3(11): e712-e723.
[44]. Stichting NICE (Nationale Intensive Care Evaluation). COVID-19 in Dutch nursing wards: Patient characteristics and outcomes [COVID-19 op de Nederlandse verpleegafdelingen: Patiëntkarakteristieken en uitkomsten]. Version 3 Aug 2021. https://www.stichting-nice.nl/COVID_rapport_afdeling.pdf.
[45]. Stichting NICE (Nationale Intensive Care Evaluation). COVID-19 in Dutch Intensive Care Units: Patient characteristics and outcomes compared with pneumonia patients in the ICU from 2017-2019. Version 3 Aug 2021. https://stichting-nice.nl/COVID_report.pdf
[46]. Haagsma, J. A., De Noordhout, C. M., Polinder, S. et al. Assessing disability weights based on the responses of 30,660 people from four European countries. Popul Health Metrics 2015;13(1):1-15.